- Book
- April 2024
- 448 Pages
- Book
- April 2023
- 128 Pages
- Book
- April 2023
- 176 Pages
- Book
- September 2022
- 304 Pages
- Book
- September 2021
- 304 Pages
- Book
- December 2019
- 432 Pages
- Book
- November 2019
- 432 Pages
- Book
- January 2019
- 264 Pages
- Book
- January 2019
- 600 Pages
- Book
- March 2018
- 112 Pages
- Book
- January 2017
- 488 Pages
- Book
- January 2016
- 952 Pages
- Book
- April 2014
- 344 Pages
- Book
- April 2013
- 296 Pages
- Book
- April 2013
- 256 Pages
- Book
- November 2012
- 240 Pages
- Book
- April 2012
- 776 Pages
- Book
- November 2011
- 432 Pages
- Book
- November 2010
- 232 Pages
- Book
- April 2008
- 538 Pages

The Platelet market is a segment of the pharmaceutical industry that focuses on the production and distribution of platelet-based products. Platelets are a type of blood cell that helps the body form clots to stop bleeding. Platelet-based products are used to treat a variety of conditions, including bleeding disorders, cancer, and autoimmune diseases. Platelet-based products are also used in the treatment of traumatic injuries, such as those caused by surgery or accidents.
The Platelet market is highly regulated, with stringent safety and quality standards in place to ensure the safety and efficacy of the products. Companies in the Platelet market must adhere to these standards in order to remain competitive.
Companies in the Platelet market include CSL Behring, Grifols, Octapharma, Kedrion, and Shire. These companies produce a variety of platelet-based products, including platelet concentrates, platelet-rich plasma, and platelet lysates. Show Less Read more